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Coronaviruses (CoV) cause diseases in birds, 
mammals, and humans, and were first identified in the 
mid-1960s (Lee, 2015; Bande et al., 2015; CDC, 2020). 
These viruses are named for the crown-like spikes on 
their surface (CDC, 2020). Based on the classification of 
the International Committee for Taxonomy of Viruses 
(ICTV) coronaviruses are from order Nidovirales, family 
Coronaviridae and subfamily Coronavirinae.  The 
viruses contain a positive sense, single-stranded 
Ribonucleic acid (RNA) genome ranged from 26 to 32 
kilobases (kb) in length and thus have the largest 
genomes for RNA viruses (van Regenmortel et al., 
2000). These viruses are further divided into four main 
subgroups named alpha, beta, gamma, and delta. There 
are seven human coronaviruses cause infection in 
humans including HCoV-229E (alpha coronavirus), 
HCoV-NL63 (alpha coronavirus), HCoV-OC43 (beta 
coronavirus), HCoV-HKU1 (beta coronavirus), Middle 
East Respiratory Syndrome, or MERS-CoV (beta 
coronavirus), Severe Acute Respiratory Syndrome, or 
SARS-CoV (beta coronavirus), and the newly identified 
2019 Novel Coronavirus (2019-nCoV) (CDC, 2020), 
defined as SARS-CoV2, causing the Coronavirus Virus 
Disease of 2019 (COVID-19).  
 Ahmad & Rodriguez-Morales – Emergence of 2019-novel Coronavirus: a new threat from China 
38 
 
 
Rev Panam Enf Inf 2019; 2(2):37-38. 
Common symptoms of the disease include fever, 
cough, respiratory symptoms, shortness of breath and 
breathing difficulties (WHO, 2020), but patients can 
complicate and even evolve to fatal outcomes.  
In December 2019, the Wuhan city, Hubei province 
of China, reported several cases of pneumonia of 
unknown etiology (Wuhan Municipal Health 
Commission, 2019). In January 2020, the causative agent 
was confirmed as 2019-nCoV (Xinhuanet, 2020). The 
number of cases has been increased in the last few weeks. 
As of February 12, 2020, a total of 45,204, confirmed 
cases of 2019-nCoV had been reported globally. Of the 
reported cases, 44,685 cases were from mainland China. 
The number of deaths increased and reached to 1,116 
(Figure 1). The infection was spread beyond the border 
and 25 countries have been reported cases of 2019-nCoV 
including the United States, Singapore, Japan, Thailand, 
Australia, Republic of Korea, Malaysia, Germany, 
France and other countries (WHO, 2020a). 
Thus, it is imperative to strengthen the public health 
system, disease surveillance, and control suspected cases 
of 2019-nCoV, early detection and diagnosis, to avoid 
and control further spreading of 2019-nCoV. More joint 
efforts from the World Health Organization (WHO), the 
Chinese government, health institutes, researchers are 
needed in addition to regional efforts to provide and 
establish policies, guidelines and proper surveillances. 
There are more elements of concern in the current 2019-
nCoV, such as cross border movement, and regional 
cooperation. Therefore, some strict actions should be 
taken to curb the disease and prevent further spreading. 
2019-nCoV can be transmitted from person to person and 
should be considered an emerging human pathogen and 
a new threat to the world. 
 
References 
1. Centre for Disease Control and Prevention (CDC). Human 
Coronavirus Types. National Center for Immunization and 
Respiratory Diseases (NCIRD), Division of Viral Diseases, 
January 10, 2020. Available from: 
https://www.cdc.gov/coronavirus/types.html (accessed on 09 
February 2020). 
2. World Health Organization (WHO). Coronavirus. WHO. 2020. 
Available from: https://www.who.int/health-topics/coronavirus 
(accessed on 09 February 2020). 
3. van Regenmortel MHV, Fauquet CM, Bishop DHL, Carstens 
EB, Estes MK, Lemon SM, et al. Coronaviridae. In: MHV v R, 
Fauquet CM, DHL B, Carstens EB, Estes MK, Lemon SM, et 
al., editors. Virus taxonomy: Classification and nomenclature of 
viruses Seventh report of the International Committee on 
Taxonomy of Viruses. San Diego: Academic Press; 2000. p. 
835–49. ISBN 0123702003. 
4. Lee C. Porcine epidemic diarrhea virus: An emerging and re-
emerging epizootic swine virus. Virol J. 2015;12(1):193. 
5. Bande F, Arshad SS, Hair Bejo M, Moeini H, Omar AR. 
Progress and challenges toward the development of vaccines 
against avian infectious bronchitis. J Immunol Res. 2015;2015. 
https://doi.org/10.1155/2015/424860. 
6. XINHUANET. New-type coronavirus causes pneumonia in 
Wuhan: expert. Released on 9 Jan 2020. Available from: 
http://www.xinhuanet.com/english/2020-
01/09/c_138690570.htm (accessed on 09 February 2020). 
7. Report of clustering pneumonia of unknown etiology in Wuhan 
City. Wuhan Municipal Health Commission, 2019. Available 
from: 
http://wjw.wuhan.gov.cn/front/web/showDetail/201912310898
9: In Chinese (accessed on 09 February 2020). 
8. Novel coronavirus (2019-nCoV) situation as of 09 February 
2020, 16:00 (CET). World Health Organization. Available from: 
http://who.maps.arcgis.com/apps/opsdashboard/index.html#/c8
8e37cfc43b4ed3baf977d77e4a0667 (accessed on 10 February 
2020). 
 
Corresponding Author: Prof. Alfonso J. Rodriguez-Morales, 
Public Health and Infection Research Group, Faculty of Health 
Sciences, Universidad Tecnologica de Pereira, Pereira, 
Risaralda, Colombia. Email: arodriguezm@utp.edu.co   
 
Conflict of interest: None, all authors. 
